Higenamine has been demonstrated to increase the anticancer activity (apoptosis and G2/M cell cycle arrest) of cucurbitacin B in breast cancer (T47D and SkBr3) cells by inhibiting Akt and CDK2 [108]. Here, AKT1 is linked to breast carcinoma.